Paradigm Capital Management Inc. NY Buys 80,000 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Paradigm Capital Management Inc. NY raised its stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 25.0% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 400,000 shares of the company’s stock after purchasing an additional 80,000 shares during the period. Paradigm Capital Management Inc. NY’s holdings in Viemed Healthcare were worth $2,620,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. New York State Teachers Retirement System bought a new stake in shares of Viemed Healthcare during the 1st quarter valued at $29,000. Evernest Financial Advisors LLC purchased a new stake in Viemed Healthcare in the 2nd quarter worth $66,000. Price T Rowe Associates Inc. MD bought a new stake in Viemed Healthcare during the first quarter valued at about $97,000. Victory Capital Management Inc. lifted its position in shares of Viemed Healthcare by 21.1% in the second quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock valued at $84,000 after acquiring an additional 2,226 shares in the last quarter. Finally, Pinnacle Wealth Planning Services Inc. bought a new position in shares of Viemed Healthcare in the first quarter worth about $135,000. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Stock Performance

NASDAQ:VMD opened at $7.31 on Tuesday. The stock has a 50-day moving average price of $7.27 and a 200 day moving average price of $7.56. The company has a current ratio of 1.43, a quick ratio of 1.29 and a debt-to-equity ratio of 0.07. Viemed Healthcare, Inc. has a 12-month low of $5.90 and a 12-month high of $10.44. The stock has a market capitalization of $283.78 million, a P/E ratio of 28.12 and a beta of 1.47.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.03). Viemed Healthcare had a net margin of 4.60% and a return on equity of 8.23%. The company had revenue of $54.97 million for the quarter.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.